A familiar mouth bacterium best known for causing cavities may also be quietly influencing the brain. Scientists found that ...

Northwestern Medicine scientists have discovered that targeting neuronal signaling controlling aberrant learning in the ...

Patient-centric trial aiming to evaluate whether bezisterim can help delay disease progression reaches enrollment milestone -- Topline Results ...

A new UCLA Health study links long-term residential exposure to the pesticide chlorpyrifos with a substantially higher risk of developing Parkinson’s disease. A study led by UCLA Health reports that p ...

Parkinson's disease is no longer viewed as a faraway neurological ailment buried in textbooks. More than 10 million people ...

The President of IMANI Africa, Franklin Cudjoe, has publicly disclosed that he has been living with Parkinson’s disease for ...

Stevenage, United Kingdom Saturday, January 10, 2026, 14:00 Hrs [IST] ...

A Vancouver General Hospital neurosurgeon is working on new research that could help Parkinson’s patients suffering from ...

NRG5051 is a first-in-class, orally bioavailable and CNS-penetrant next-generation inhibitor of the mitochondrial permeability transition pore (mPTP), acting through a novel undisclosed ...

SynuSight Biotech has licensed (18) F-FD4 to XingImaging and to ABLi Therapeutics to evaluate alpha-synuclein clearance from the brain in response to risvodetinib treatment ...

This perspective argues that Parkinson’s disease may involve functional iron deficiency, where bioavailable iron is limited despite normal or elevated total iron in the brain. The authors propose that ...